Others
- Page Path
-
- HOME
- ARTICLE CATEGORY
- Others
- Snapshot
- Microbiome and metabolomics in alcoholic liver disease
- Raja Ganesan, Ki Tae Suk
- Clin Mol Hepatol. 2022;28(3):580-582. Published online July 1, 2022
- Letter to the Editor
- Clinical significance of the discrepancy between radiological findings and biochemical responses in atezolizumab plus bevacizumab for hepatocellular carcinoma
- Hideki Iwamoto, Shigeo Shimose, Takashi Niizeki, Hironori Koga, Takuji Torimura
- Clin Mol Hepatol. 2022;28(3):575-579. Published online April 21, 2022
- Editorial
- Association of nonalcoholic fatty liver disease with incident dementia later in life among elderly adults
- Byoung Seok Ye
- Clin Mol Hepatol. 2022;28(3):481-482. Published online May 16, 2022
- A crystal ball to forecast treatment responsiveness in nonalcoholic fatty liver disease
- Seonghwan Hwang, Won Kim
- Clin Mol Hepatol. 2022;28(3):478-480. Published online June 16, 2022
- Does nonalcoholic fatty liver disease predispose patients to carotid arteriosclerosis and ischemic stroke?
- Qian Jin, Rui-Xu Yang, Jian-Gao Fan
- Clin Mol Hepatol. 2022;28(3):473-477. Published online June 22, 2022
- Guideline
- KASL clinical practice guidelines for management of chronic hepatitis B
- Clin Mol Hepatol. 2022;28(2):276-331. Published online April 1, 2022
- Snapshot
- Acute on chronic liver failure in cirrhosis
- Marta Tonon, Salvatore Piano
- Clin Mol Hepatol. 2022;28(2):273-275. Published online February 14, 2022
- Letter to the Editor
- Effects of interleukin-17 inhibitors on hepatic fibrosis index in patients with psoriasis and metabolic dysfunction-associated fatty liver disease: Directed acyclic graphs
- Saori Takamura, Yuichi Teraki, Eri Katayama, Takumi Kawaguchi, Machiko Kawaguchi, Dan Nakano, Tsubasa Tsutsumi, Sumiko Nagoshi, Takekuni Nakama, Takuji Torimura
- Clin Mol Hepatol. 2022;28(2):269-272. Published online February 15, 2022
- Reply: Letter: cervicocerebral atherosclerosis and its hepatic and coronary risk factors in patients with liver cirrhosis
- Jihyun An, Ju Hyun Shim
- Clin Mol Hepatol. 2022;28(2):267-268. Published online January 18, 2022
- Letter: cervicocerebral atherosclerosis and its hepatic and coronary risk factors in patients with liver cirrhosis
- Yi-Chun Huang, Chih-Wei Chen, James Chun-Chung Wei
- Clin Mol Hepatol. 2022;28(2):265-266. Published online January 4, 2022
- Editorial
- Dyslipidemia in chronic hepatitis B patients on tenofovir alafenamide: Facts and puzzles
- Hung-Yao Lin, Tai-Chung Tseng
- Clin Mol Hepatol. 2022;28(2):181-182. Published online February 21, 2022
- Leaky gut-derived tumor necrosis factor-α causes sarcopenia in patients with liver cirrhosis
- Takumi Kawaguchi, Takuji Torimura
- Clin Mol Hepatol. 2022;28(2):177-180. Published online August 26, 2021
- Surgical resection versus ablation for early hepatocellular carcinoma: The debate is still open
- Bo Hyun Kim
- Clin Mol Hepatol. 2022;28(2):174-176. Published online January 26, 2022
- Snapshot
- Current status and outcome of liver transplantation in South Korea
- Ho Joong Choi
- Clin Mol Hepatol. 2022;28(1):117-119. Published online December 7, 2021
- Editorial
- Non-alcoholic fatty liver disease in pregnancy, paving the way for adverse pregnancy outcome risk assessment
- Ja-Young Kwon
- Clin Mol Hepatol. 2022;28(1):50-51. Published online November 22, 2021
- Nonalcoholic fatty liver disease-based risk prediction of adverse pregnancy outcomes: Ready for prime time?
- Seung Mi Lee, Won Kim
- Clin Mol Hepatol. 2022;28(1):47-49. Published online November 30, 2021
- Snapshot
- History and future of hepatitis B virus control in South Korea
- Do Young Kim
- Clin Mol Hepatol. 2021;27(4):620-622. Published online September 23, 2021
- Letter to the Editor
- Impact of branched-chain amino acids and frailty on the management of lenvatinib-related fatigue in patients with hepatocellular carcinoma
- Shigeo Shimose, Shunji Koya, Takumi Kawaguchi, Keisuke Hirota, Sachiyo Yoshio, Takashi Niizeki, Hiroo Matsuse, Takuji Torimura
- Clin Mol Hepatol. 2021;27(4):616-619. Published online September 13, 2021
- Editorial
- Can hepatocellular carcinoma recurrence be prevented after liver transplantation?
- Jong Man Kim
- Clin Mol Hepatol. 2021;27(4):562-563. Published online September 23, 2021
- Microwave thermosphere versus radiofrequency ablation for hepatocellular carcinoma: Are we approaching the time to end the debate?
- Man-Deuk Kim
- Clin Mol Hepatol. 2021;27(4):560-561. Published online September 8, 2021
- Special Topic
- Update on liver disease management during the pandemic of coronavirus disease 2019 (COVID-19): 2021 KASL guideline
- Ju-Yeon Cho, Young-Sun Lee, Soon Sun Kim, Do Seon Song, Jeong-Hoon Lee, Ji Hoon Kim
- Clin Mol Hepatol. 2021;27(4):515-523. Published online September 17, 2021
- Snapshot
- Hepatocellular carcinoma statistics in South Korea
- Young Eun Chon, Soung Won Jeong, Dae Won Jun
- Clin Mol Hepatol. 2021;27(3):512-514. Published online June 21, 2021
- Letter to the Editor
- The major diagnostic role of autoantibodies in the diagnosis of autoimmune hepatitis, a disease of all ages
- Linda Beenet
- Clin Mol Hepatol. 2021;27(3):510-511. Published online March 22, 2021
- Editorial
- Risk of hepatocellular carcinoma in untreated patients with chronic hepatitis B: Independent of HBeAg status?
- Ho Soo Chun, Minjong Lee
- Clin Mol Hepatol. 2021;27(3):448-450. Published online June 23, 2021
- An analysis of polygenic risk scores for non-alcoholic fatty liver disease
- Dae Won Jun
- Clin Mol Hepatol. 2021;27(3):446-447. Published online May 21, 2021
- Guideline
- KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease
- Seong Hee Kang, Hye Won Lee, Jeong-Ju Yoo, Yuri Cho, Seung Up Kim, Tae Hee Lee, Byoung Kuk Jang, Sang Gyune Kim, Sang Bong Ahn, Haeryoung Kim, Dae Won Jun, Joon-Il Choi, Do Seon Song, Won Kim, Soung Won Jeong, Moon Young Kim, Hong Koh, Sujin Jeong, Jin-Woo Lee, Yong Kyun Cho
- Clin Mol Hepatol. 2021;27(3):363-401. Published online June 22, 2021
- Letter to the Editor
- Clinical and serological prognostic markers in primary biliary cholangitis
- Markus Wilhelmi
- Clin Mol Hepatol. 2021;27(2):360-361. Published online March 23, 2021
- Editorial
- Another oral antiviral treatment, but still far away from hepatitis B virus cure
- Tai-Chung Tseng
- Clin Mol Hepatol. 2021;27(2):281-282. Published online March 10, 2021
- Biopsy or cytology for diagnosing hepatic focal lesions?
- Haeryoung Kim
- Clin Mol Hepatol. 2021;27(2):278-280. Published online March 4, 2021
- Negligible risk of hepatocellular carcinoma in chronic hepatitis B patients in immune-tolerant phase: Myth or fact
- Terry Cheuk-Fung Yip, Grace Lai-Hung Wong, Vincent Wai-Sun Wong
- Clin Mol Hepatol. 2021;27(2):273-277. Published online February 1, 2021
-
Clinical and
Molecular
HepatologyPrint ISSN: 2287-2728
Online ISSN: 2287-285X
-
-
- Artificial intelligence in hepatology, Guest editor: Jeong Won Jang, M.D.
- Novel biomarkers for hepatocellular carcinoma, Guest editor: Bo Hyun Kim, M.D.
- Recent update on therapeutics for NAFLD, Guest editor: Won Kim, M.D.
- Interactions between metabolic phenotypes and chronic liver diseases, Guest editor: Dae Won Jun, M.D.
- All about risk models in hepatocellular carcinoma, Guest editor: Ji Hoon Kim, M.D.
First decision
09 Days
Publication after acceptance
07 Days
*Last 12 months
- MOST VIEWED (Last 6 months)
- MOST CITED (2020-2022)
|
|||||||
